BioSpace News Archive

BioAgilytix Labs is pleased to announce the appointment of Kennon Broadhurst to its Commercial Leadership team as Vice President of Global Marketing.

LUNGevity Foundation, the nation’s premier lung cancer-focused nonprofit organization, announced today that Maximilian Diehn, MD, PhD, has joined its Scientific Advisory Board.

ARCpoint Labs offers free Webinar on Sept. 30, 2020 to help identify proper tests, safe ways to return to work and school.

Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg). No dose limiting toxicities were reported. A majority of patients reported meaningful pain reduction of 30% or more from baseline. Sorrento expects to submit to the FDA a request to proceed with a Phase 3 clinical trial in this orphan indication imminently. SAN DIEGO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced the public release of the results of it

Michael Einodshofer, RPh, MBA, Chief Pharmacy Officer at Maxor assumes role of Chairman of the Board for the National Association of Specialty Pharmacy

BGI & MGI provide founding member Task Force Lab (TFL) immediate access to US FDA EUA COVID-19 testing equipment and reagents to ramp up capacity and reduce turnaround times [22-September-2020] SAN JOSE, Calif. , Sept. 22, 2020 /PRNewswire/ -- Today, BGI and MGI announced a clinical lab partnership program designed to accelerate population-level testing to help

Wisconsin Pharmacal Company, LLC has announced that Andrew Wundrock has been appointed to the position of President of the company effective September 2020.

Mercury Medical,announces the appointment of Raymond L. Mundy to the newly created position, Executive Vice President - Sales and Marketing.

- Athira Pharma, Inc., (Nasdaq: ATHA) (“ Athira ”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the closing of its initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will participate in a Fireside Chat at the H.C. Wainwright Precision Oncology Conference on Thursday, September 24, 2020 at 9:30 a.m. Eastern Standard Time. A video webcast will be available on the